| Title |
Botulinum toxin injections for low‐back pain and sciatica
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2011
|
| DOI | 10.1002/14651858.cd008257.pub2 |
| Pubmed ID | |
| Authors |
Zeeshan Waseem, Chris Boulias, Allan Gordon, Farooq Ismail, Geoffrey Sheean, Andrea D Furlan |
| Abstract |
Adequate relief from low-back pain (LBP) is not always possible. Emerging evidence suggests a role for botulinum neurotoxin (BoNT) injections in treating pain disorders. Proponents of BoNT suggest its properties can decrease muscle spasms, ischemia and inflammatory markers, thereby reducing pain. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 50% |
| United Kingdom | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 226 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Norway | 1 | <1% |
| Unknown | 225 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 13% |
| Student > Bachelor | 30 | 13% |
| Researcher | 24 | 11% |
| Student > Postgraduate | 21 | 9% |
| Student > Ph. D. Student | 20 | 9% |
| Other | 54 | 24% |
| Unknown | 47 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 93 | 41% |
| Nursing and Health Professions | 27 | 12% |
| Agricultural and Biological Sciences | 13 | 6% |
| Psychology | 6 | 3% |
| Business, Management and Accounting | 4 | 2% |
| Other | 23 | 10% |
| Unknown | 60 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2021.
All research outputs
#4,857,628
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,973
of 11,499 outputs
Outputs of similar age
#30,526
of 193,914 outputs
Outputs of similar age from Cochrane database of systematic reviews
#53
of 119 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,914 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.